| Biotechnology Industry | Healthcare Sector | Ms. Mulin Chen CEO | SSE Exchange | CNE1000042Q8 ISIN |
| CN Country | 923 Employees | 26 May 2026 Last Dividend | - Last Split | - IPO Date |
Wuhan Keqian Biology Co.,Ltd is a renowned entity committed to the advancement of veterinary biological products. Established in 2001 and rooted in Wuhan, China, the company has carved a niche for itself in the realm of animal health. Their core activities span across research and development, manufacturing, sales, and the provision of technical services related to animal epidemic prevention. Their operations are especially focused on serving the vast Chinese market, addressing the health needs of swine, poultry, and pets with a comprehensive range of products and solutions.
At the heart of Wuhan Keqian Biology Co.,Ltd's offerings are its scientifically formulated veterinary biological products designed to enhance the well-being and health of animals. Below are their key products and associated services: